In a landmark move, the FDA has approved a federally regulated clinical trial to study how cannabis use impacts veterans with post-traumatic stress disorder (PTSD). This study, led by the Multidisciplinary Association for Psychedelic Studies (MAPS), aims to explore the real-world effects of cannabis on PTSD symptoms, paving the way for innovative treatments tailored to the needs of veterans.
Key Details About the Study
Focus on Veterans: The study will include 320 veterans with moderate to severe PTSD, making it one of the largest federally approved cannabis trials to date.
Real-World Cannabis Use: Participants will use cannabis products similar to those available in commercial dispensaries, with potencies of around 20% THC. They can select their own doses, up to 1.5 grams daily, to mimic real-world use.
Inhalation Methods: Unlike previous studies, this trial focuses on methods commonly used by consumers, such as smoking or vaping, to provide more practical insights.
Why This Study Matters
Veterans advocacy groups have long called for more research into alternative treatments for PTSD, particularly cannabis. Between 2013 and 2022, cannabis use among Americans more than doubled, with veteran usage also increasing significantly. Nearly 1 in 10 veterans reported using marijuana in 2019, highlighting a growing interest in its potential therapeutic benefits.
Potential Benefits for Veterans
Tailored Treatments: The study’s flexible dosing allows veterans to adjust their cannabis use based on their symptoms, offering a personalized approach to PTSD management.
New Data for Policymakers: The results could inform future federal policies, including potential changes to the VA’s stance on cannabis.
Advancing Research: With cannabis still classified as a Schedule I drug, this study represents progress toward understanding its medical potential and risks.
Challenges Veterans Face with Cannabis Use
Despite growing acceptance, veterans still face significant barriers:
VA Restrictions: VA clinicians cannot prescribe cannabis, even in states where medical use is legal.
Stigma in Medical Records: Veterans who use cannabis may be flagged as drug abusers in medical records, complicating future treatment plans.
Lack of Federal Guidance: The absence of a unified federal policy leaves veterans navigating a patchwork of state laws, making it difficult to discuss cannabis use openly with healthcare providers.
Veterans Leading the Way for Federal Cannabis Reform
Veterans are at the forefront of cannabis advocacy, pushing for reclassification and broader acceptance of cannabis as a treatment option. Patrick Murray of the Veterans of Foreign Wars highlights the importance of this movement, stating, “I don’t think that we’ll see cannabis move forward federally without it being led by veterans.”
This FDA-approved study could be a turning point, providing the high-quality data needed to address both the benefits and risks of cannabis for PTSD treatment.
What’s Next?
As the study progresses, it will serve as a crucial step toward understanding how cannabis can fit into veterans’ healthcare. With the potential for federal rescheduling of cannabis on the horizon, the results could influence how the VA and other institutions approach cannabis in the future.
OMNI Medical Supports Veterans
At OMNI Medical, we are committed to supporting veterans in their journey to find effective treatments. If you’re using medical cannabis, ensure your card is up to date to maintain access to high-quality products and care.
👉 Contact OMNI Medical today to renew your card or learn more about medical cannabis options.
Comments